More Globe Newswire

View Older Stories View Newer Stories

Jan 27, 2025 08:04AM Novo Nordisk A/S - share repurchase programme
Jan 27, 2025 08:00AM Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium
Jan 27, 2025 08:01AM Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Jan 27, 2025 08:00AM DYOR Partners with Ava Labs, Announces Major Developments With Matt Dyor Joining as Advisor Plus Acquisition of DYOR.com
Jan 27, 2025 08:00AM Stoopid Cats Revolutionizes P2E Gaming: 100K Players, $250K Raised, and Dividend NFTs
Jan 27, 2025 08:00AM GDC Discontinues Livestreaming Gaming Business
Jan 27, 2025 08:00AM LexisNexis Introduces Protégé Personalized AI Assistant with Agentic AI, Making it Easier to Power Complex Legal Task Completion
Jan 27, 2025 08:00AM SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE
Jan 27, 2025 08:00AM MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs
Jan 27, 2025 08:00AM Kratos Unmanned Systems Demonstrates Leader Follower Platooning Technology in Quebec's Forestry Sector in a Timber Hauling Operation
Jan 27, 2025 08:00AM American Hotel Income Properties REIT LP Announces Completion of CMBS Refinancing and Reduction of Senior Credit Facility
Jan 27, 2025 08:00AM Townsquare Forms Strategic Alliance with Steel City Media
Jan 27, 2025 08:00AM Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025
Jan 27, 2025 08:00AM Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer
Jan 27, 2025 08:00AM AmMax Bio Announces First Patient Dosed in Phase 2a Study Evaluating AMB-066 in Patients with Colorectal Cancer Minimal Residual Disease
Jan 27, 2025 08:00AM Flock Safety and ForceMetrics Ink Partnership to Improve Community and Law Enforcement Safety
Jan 27, 2025 08:00AM Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Third Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending April, May, and J
Jan 27, 2025 08:00AM Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women
Jan 27, 2025 08:00AM DECEMBER 2024: ELFA CapEx Finance Index Shows New Business Volumes Surged at Year-End
Jan 27, 2025 08:00AM The Colt Group Acquires RJ Stacey
Jan 27, 2025 08:00AM Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
Jan 27, 2025 08:00AM Commencement of a new plan period in the share-based Long-Term Incentive Plan for management and key employees
Jan 27, 2025 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Jan 27, 2025 08:00AM Municipality Finance will redeem early notes issued under its MTN programme
Jan 27, 2025 07:33AM M42’s Danat Al Emarat Hospital for Women & Children partners with ProFaM to offer revolutionary reproductive health services
Jan 27, 2025 07:30AM Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
Jan 27, 2025 07:30AM Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
Jan 27, 2025 07:30AM Habit Burger & Grill Celebrates Grand Opening at Sacramento State
Jan 27, 2025 07:01AM Form 8.3 - [ International Paper Company]
Jan 27, 2025 07:02AM First commercial launch of biometric payment cards in Japan with LIFE CARD and IDEX Biometrics
Jan 27, 2025 07:01AM Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA’s Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mil
Jan 27, 2025 07:00AM Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
Jan 27, 2025 07:00AM US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug
Jan 27, 2025 07:00AM GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies
Jan 27, 2025 07:00AM Get Ready for the Ultimate Game Day with Tilray Brands: Nationwide Brewery Events!
Jan 27, 2025 07:00AM EnviroGold Global Announces Strategic Alliance with Global Leader Fraser Alexander to Collaborate on Sustainable Mining Projects
Jan 27, 2025 07:00AM Xunlei to Acquire Hupu
Jan 27, 2025 07:00AM Plug Power Boosts Liquidity with $30 Million Federal Investment Tax Credit Transfer
Jan 27, 2025 07:00AM Blackford Capital Acquires Ace Controls, Expanding PACIV, its Industrial Automation Platform
Jan 27, 2025 07:00AM QXO Launches $11 Billion Tender Offer to Acquire Beacon Roofing Supply for $124.25 Per Share in Cash
Jan 27, 2025 07:00AM Gadfin Ltd. and Israel Acquisitions Corp. Announce Entry into Definitive Business Combination Agreement, Bringing the Unmanned Aerial Delivery Company to Nasdaq
Jan 27, 2025 07:00AM Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
Jan 27, 2025 07:00AM PyroGenesis Signs $2.5 Million Contract with Global Environmental Services Company
Jan 27, 2025 07:00AM Hopebridge celebrates 20 years of compassionate autism care
Jan 27, 2025 07:00AM Gauzy Invited by Israel’s Minister of Economy and Industry to Participate in Prestigious Economic Forum Designed to Foster Collaboration Between Israeli and Indian Companies
Jan 27, 2025 07:00AM Proposals by the Nomination Board to the Annual General Meeting 2025 of Suominen
Jan 27, 2025 07:00AM Schouw & Co. share buy-back programme, week 4 2025
Jan 27, 2025 06:34AM Holding(s) in Company
Jan 27, 2025 06:30AM Correction: Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
Jan 27, 2025 06:30AM Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19
View Newer Stories View Older Stories